NCT06846710 - Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118 | Biotech Hunter

Enrollment

132

Participants

Timeline

Start Date

May 2, 2025

Primary Completion Date

October 30, 2026

Study Completion Date

February 28, 2027

Conditions

Psoriasis

Interventions

DRUG

HS-20118

Single and multiple ascending doses of HS-20118 orally

OTHER

HS-20118 placebo

Single and multiple ascending doses of HS-20118-matched placebo orally

Trial Locations (9)

NOT_YET_RECRUITING

Momentum Clinical Research, Pukekohe, Pukekohe

NOT_YET_RECRUITING

Pacific Clinical Research Network (PCRN), Wellington, Upper Hutt

NOT_YET_RECRUITING

Momentum Clinical Research, Wellington, Mount Cook

NOT_YET_RECRUITING

Pacific Clinical Research Network (PCRN), Christchurch, Christchurch

NOT_YET_RECRUITING

Momentum Clinical Research, Dunedin, Dunedin

NOT_YET_RECRUITING

Clinitiative - Floridian Clinical Research, LLC, Miami Lakes

NOT_YET_RECRUITING

NuLine Clinical Trial Center (Network), Pompano Beach

NOT_YET_RECRUITING

Kinetic Clinical Research, Anaheim

RECRUITING

Pacific Clinical Research Network (PCRN), Auckland, Takapuna